Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)
- PMID: 1665907
- DOI: 10.1093/protein/4.7.785
Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)
Abstract
Single amino acid substitutions were generated in predicted hydrophilic loop regions of the human tumour necrosis factor beta (TNF-beta) molecule, and the mutant proteins were expressed in Escherichia coli and purified. Mutants with single amino acid changes at either of two distinct loop regions, at positions aspartic acid 50 or tyrosine 108, were found to have greatly reduced receptor binding and cytotoxic activity. These two regions in TNF-beta correspond to known loop regions where mutations also result in loss of biological activity of TNF-alpha, a related cytokine which shares the same cellular receptors with TNF-beta. The two distinct loops at positions 31-34 and 84-89 in the known three-dimensional structure of TNF-alpha (equivalent to positions 46-50 and 105-110 respectively in TNF-beta), lie on opposite sides of the TNF-alpha monomer. When the TNF-alpha monomer forms a trimer, the two loops, each from a different subunit of the trimer, come together and lie in a cleft between adjacent subunits. Together, these findings suggest that a TNF receptor binds to a cleft between subunits via surface loops at amino acid residues 31-34 and 84-89 in TNF-alpha, and similarly via surface loops including amino acids aspartic acid 50 and tyrosine 108 in TNF-beta.
Similar articles
-
Galloway Memorial Lecture. Protein engineering of tumor necrosis factor-beta and its applications in cancer, septicaemia and cachexia.Ann Acad Med Singap. 1993 Jul;22(4):651-6. Ann Acad Med Singap. 1993. PMID: 8257076
-
Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.J Biol Chem. 1992 Nov 25;267(33):24069-75. J Biol Chem. 1992. PMID: 1331108
-
The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.J Biol Chem. 1989 Oct 15;264(29):17595-605. doi: 10.2210/pdb1tnf/pdb. J Biol Chem. 1989. PMID: 2551905
-
Structural and functional domains in human tumour necrosis factors.Protein Eng. 1991 Apr;4(4):385-9. doi: 10.1093/protein/4.4.385. Protein Eng. 1991. PMID: 1715560 Review.
-
Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review.
Cited by
-
Biochemical and structural characterization of the human TL1A ectodomain.Biochemistry. 2009 Aug 18;48(32):7636-45. doi: 10.1021/bi900031w. Biochemistry. 2009. PMID: 19522538 Free PMC article.
-
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.J Clin Invest. 2006 Jun;116(6):1525-34. doi: 10.1172/JCI22513. Epub 2006 May 4. J Clin Invest. 2006. PMID: 16680194 Free PMC article.
-
Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction.Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19896-901. doi: 10.1073/pnas.1310838110. Epub 2013 Nov 18. Proc Natl Acad Sci U S A. 2013. PMID: 24248355 Free PMC article.
-
A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis.PLoS Comput Biol. 2010 Feb 5;6(2):e1000669. doi: 10.1371/journal.pcbi.1000669. PLoS Comput Biol. 2010. PMID: 20140191 Free PMC article.
-
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.J Biol Chem. 2003 Oct 3;278(40):38220-8. doi: 10.1074/jbc.M306852200. Epub 2003 Jul 16. J Biol Chem. 2003. PMID: 12867412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources